Apyx Medical (APYX) Competitors

BrainsWay (NASDAQ:BWAY) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

Do institutionals & insiders have more ownership in BWAY or APYX?

30.1% of BrainsWay shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 19.0% of BrainsWay shares are held by insiders. Comparatively, 16.8% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts rate BWAY or APYX?

BrainsWay presently has a consensus target price of $14.25, indicating a potential upside of 33.30%. Given BrainsWay's stronger consensus rating and higher probable upside, equities analysts clearly believe BrainsWay is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrainsWay	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Apyx Medical	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.67

Which has more risk and volatility, BWAY or APYX?

BrainsWay has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.

Does the media favor BWAY or APYX?

In the previous week, BrainsWay had 4 more articles in the media than Apyx Medical. MarketBeat recorded 5 mentions for BrainsWay and 1 mentions for Apyx Medical. BrainsWay's average media sentiment score of 0.80 beat Apyx Medical's score of 0.29 indicating that BrainsWay is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrainsWay	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer BWAY or APYX?

Apyx Medical received 8 more outperform votes than BrainsWay when rated by MarketBeat users. However, 67.31% of users gave BrainsWay an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote.

Company	Underperform	Outperform
BrainsWay	Outperform Votes 70 67.31%	Underperform Votes 34 32.69%
Apyx Medical	Outperform Votes 78 60.94%	Underperform Votes 50 39.06%

Which has better valuation & earnings, BWAY or APYX?

BrainsWay has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than BrainsWay, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrainsWay	$43.46M	4.64	-$4.20M	$0.20	53.45
Apyx Medical	$47.29M	1.19	-$18.71M	-$0.55	-2.71

Is BWAY or APYX more profitable?

BrainsWay has a net margin of 3.88% compared to Apyx Medical's net margin of -58.59%. BrainsWay's return on equity of 3.52% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrainsWay	3.88%	3.52%	2.26%
Apyx Medical	-58.59%	-137.98%	-36.74%

Summary

BrainsWay beats Apyx Medical on 15 of the 19 factors compared between the two stocks.